SCHEMBL9679174

SCHEMBL9679174

CCCCNC(=S)N[C@@H](Cc1ccccc1)C(=O)Nc1c(C(C)C)cccc1C(C)C

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.47
SOAT1 P35610 1/20 0.47
SIRT2 Q8IXJ6 1/20 0.46
SIRT1 Q96EB6 1/20 0.46
PSMB5 P28074 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9681008 0.87 PSMB5 (0.59) SOAT2SOAT1PSMB5
SCHEMBL9679311 0.81 SOAT2 (0.59) SOAT2SOAT1
SCHEMBL9679315 0.81 SOAT2 (0.59) SOAT2SOAT1
SCHEMBL9679677 0.80 SOAT2 (0.57) SOAT2SOAT1
SCHEMBL9680183 0.78 ANPEP (0.63) SOAT2SOAT1PSMB5
SCHEMBL9680770 0.78 LMNA (0.62) SOAT2SOAT1PSMB5
SCHEMBL9678920 0.78 SOAT2 (0.53) SOAT2SOAT1PSMB5
SCHEMBL9681111 0.76 SOAT2 (0.53) SOAT2SOAT1
SCHEMBL9679723 0.75 SOAT2 (0.57) SOAT2SOAT1PSMB5
SCHEMBL9851026 0.75 CTSL (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP disclosed